The high HRD and FGA scores observed in low- compared to high-MD cancers appears largely driven by TP53 mutant cases, consistent with previous observations from an analysis of pan-cancer TCGA data showing higher HRD and FGA in TP53-mutated tumors26,27. Here, TP53 is linked to cancer.